Amedeo Smart

Free Medical Literature Service


 

Amedeo

Malignant Lymphoma

  Free Subscription

Articles published in
Oncogene
    October 2026
  1. YOKOYAMA K, Chiba M, Takei N, Suto K, et al
    Genome-wide CRISPR screens identify an RXR-MYLIP-LDLR axis regulating BH3 mimetic sensitivity in peripheral T-cell lymphomas.
    Oncogene. 2026;45:4393-4405.
    >> Share

    June 2026
  2. WANG C, Cai MC, Cheng S, Hu S, et al
    LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signaling.
    Oncogene. 2026 Jun 29. doi: 10.1038/s41388-026-03868.
    >> Share

    November 2025
  3. GUO W, Wang X, Cui G, Schmieder EAS, et al
    Aberrant lipid metabolism renders an aggressive behavior of T-lymphoblastic lymphoma in a MASH model.
    Oncogene. 2025 Nov 26. doi: 10.1038/s41388-025-03630.
    >> Share

    October 2025
  4. CLEMENS MJ, Bushell M, Morley SJ
    Correction to: Degradation of eukaryotic polypeptide chain initiation factor (eIF) 4G in response to induction of apoptosis in human lymphoma cell lines.
    Oncogene. 2025 Oct 8. doi: 10.1038/s41388-025-03586.
    >> Share

    April 2025
  5. CHEN W, Jiang Y, Zeng J, Liu D, et al
    FDX1 promotes elesclomol-induced PANoptosis in diffuse large B-cell lymphoma via activating IRF3/IFN-beta signaling.
    Oncogene. 2025 Apr 16. doi: 10.1038/s41388-025-03366.
    >> Share

    January 2025
  6. ABD-ELRAHMAN I, Nassar T, Khairi N, Perlman R, et al
    Correction: Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma.
    Oncogene. 2025 Jan 29. doi: 10.1038/s41388-025-03282.
    >> Share

    November 2024
  7. BORDONE R, Ivy DM, D'Amico R, Barba M, et al
    MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptation.
    Oncogene. 2024;43:3349-3365.
    >> Share

    September 2023
  8. MOLINA E, Garcia-Gutierrez L, Junco V, Perez-Olivares M, et al
    MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells.
    Oncogene. 2023 Sep 29. doi: 10.1038/s41388-023-02846.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016